Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNRAY-01
ChiCTR2400084905Phase 3Not yet recruiting
- Sponsor
- Jilin Provincial Cancer Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olomorasib, sponsored by Jilin Provincial Cancer Hospital. Planned start May 2024; status: not yet recruiting.
02
Drugs
olomorasib
Beyond the preview
Go deeper on ChiCTR2400084905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084905.